Investigative Study of Local Field Potential (LFP) changes during acute and chronic Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD) patients
Objective: We aimed to investigate LFP changes during acute and chronic DBS in Parkinson’s Disease (PD) patients. Our study implies neuroplastic changes during stimulation, and…Botulinum Toxin Outcomes in Patients with Lower Limb Dystonia
Objective: To assess botulinum toxin outcomes in patients with lower limb dystonia. Background: One of the most effective treatments for dystonia is botulinum toxin (BoNT)…Retinal thickness as a marker of disease progression in progressive supranuclear palsy
Objective: We measured changes of retinal thickness, and compare them with clinical features and intracranial neurodegeneration in progressive supranuclear palsy (PSP) cohort. Background: PSP has a…Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia
Objective: 1.To determine if Botulinum toxin (BoNT) injection improves oropharyngeal swallowing in individuals with cervical dystonia (CD) as determined by objective data from videofluorographic swallowing studies…Interventions to Improve Gait in Parkinson’s Disease: A Systematic Review of Randomised Controlled Trials and Network Meta-Analysis
Objective: This systematic review and network meta-analysis sought to quantify and rank interventions targeting gait in PD. Background: Among the disabling motor symptoms of Parkinson’s…Transition from paediatric to adult care – A satisfaction survey of young people with complex motor disorders and implanted devices.
Objective: The aim of this audit was to explore the satisfaction and experience of young people with implantable Intrathecal baclofen pumps transitioning to an adult…Action verb use in PD: A challenge to the embodied cognition hypothesis?
Objective: To characterize action verb production in Parkinson's disease (PD) during a picture description task, and evaluate associations with motor and cognitive function. Background: The…Shared molecular genetic factors influence brain morphometry and Parkinson’s disease risk
Objective: To explore the genetic overlap and identify shared genomic regions between brain morphometry and Parkinson’s disease (PD) risk. Background: PD is a genetically complex…Safety of incobotulinumtoxinA in pediatrics: A pooled analysis
Objective: To present analyses of pooled data on the safety of incobotulinumtoxinA (INCO) in pediatrics Background: BotulinumtoxinA (BoNT-A) is used to treat several conditions affecting…Predicting the development of dementia in patients with Parkinson’s disease by comparing neurosteroids in the blood level
Objective: To increase the reliability of the development of dementia in patients with PD by a comparative assessment of clinical scales and neurosteroids Background: Parkinson's…
- « Previous Page
- 1
- …
- 145
- 146
- 147
- 148
- 149
- …
- 153
- Next Page »